Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
603392
Ранг среди акций
#3627
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical... Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is a biopharmaceutical firm that handles the entire process from research and development to the production, marketing, and distribution of diagnostic solutions for infectious diseases and various vaccines. The company operates extensively across China and in international markets. Its comprehensive product range offers diagnostic test kits for a multitude of infectious agents, including COVID-19, HIV, HTLV, Hepatitis, EV-71, and Tuberculosis. It also provides specific detection reagents for Hepatitis C and Syphilis. Beyond these, the portfolio includes advanced diagnostic tools such as automated immunoassays, ELISA kits, rapid diagnostic tests, and various chemiluminescence, clinical chemistry, and general immunodiagnostic reagents. Furthermore, Beijing Wantai is a developer and supplier of vaccines for Hepatitis E and human papillomavirus (HPV). The company serves a wide array of clients, including blood banks, hospitals and clinics, specialized reference laboratories, border inspection centers, blood-processing companies, and scientific research institutes. Established in 1991, Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. is headquartered in China's capital city, Beijing.
Цена акции
$3.71
Рыночная капитализация
$4.69B
Изменение (1 день)
2.44%
Изменение (1 год)
-51.92%
Страна
CN
Торговля Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Категория
Healthcare
История дивидендной доходности для Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392)
Дивидендная доходность (TTM) компании Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (тикер: 603392) на 2023-12-31 составляет: 0.96%
Средняя дивидендная доходность за последние 5 лет: 0.32%
Средняя дивидендная доходность за последние 5 лет: 0.32%
История дивидендной доходности компании Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (603392) с 2013 по 2026
Дивидендная доходность на конец каждого года (TTM)
| Год | Дивидендная доходность | Изменить |
|---|---|---|
| 2026 (TTM) | 0.00% | -100.00% |
| 2024 | 0.44% | -54.17% |
| 2023 | 0.96% | 772.73% |
| 2022 | 0.11% | 10.00% |
| 2021 | 0.10% | 0.00% |
| 2020 | 0.00% | -100.00% |
| 2019 | 0.03% | -81.25% |
| 2018 | 0.16% | 33.33% |
| 2017 | 0.12% | 0.00% |
| 2016 | 0.00% | -100.00% |
| 2015 | 2.78% | 4,533.33% |
| 2014 | 0.06% | -87.23% |
| 2013 | 0.47% | 0.00% |
Дивидендная доходность (TTM) аналогичных компаний или конкурентов
| Компания | Дивидендная доходность | Страна |
|---|---|---|
| 0.00% |
US
|
|
| 0.00% |
US
|
|
| 2.17% |
AU
|
|
| 0.00% |
CH
|
|
| 0.00% |
NL
|
